FRM
Fox Run Management’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-19,247
| Closed | -$92.2K | – | 1261 |
|
|
2024
Q4 | $92.2K | Sell |
19,247
-14,199
| -42% | -$68K | 0.02% | 812 |
|
|
2024
Q3 | $157K | Buy |
+33,446
| New | +$157K | 0.03% | 698 |
|
|
2023
Q3 | – | Sell |
-21,890
| Closed | -$144K | – | 1015 |
|
|
2023
Q2 | $144K | Buy |
+21,890
| New | +$144K | 0.04% | 617 |
|
|
2018
Q3 | – | Sell |
-28,611
| Closed | -$545K | – | 837 |
|
|
2018
Q2 | $545K | Buy |
28,611
+5,516
| +24% | +$105K | 0.17% | 205 |
|
|
2018
Q1 | $389K | Buy |
+23,095
| New | +$389K | 0.09% | 401 |
|
|
2017
Q4 | – | Sell |
-38,900
| Closed | -$696K | – | 905 |
|
|
2017
Q3 | $696K | Buy |
+38,900
| New | +$696K | 0.2% | 167 |
|
|
2017
Q2 | – | Sell |
-19,000
| Closed | -$266K | – | 856 |
|
|
2017
Q1 | $266K | Buy |
+19,000
| New | +$266K | 0.11% | 406 |
|